A Second B Cell Drug for IgA Nephropathy Was Approved in July and Two More FDA Decisions Are Due by December

FDA approved atacicept for IgA nephropathy in July. Two more drugs face decisions by year’s end. Here is what is proven and what is not.

Have A Referral?